Envestnet Asset Management’s AnaptysBio ANAB Stock Holding History

Envestnet Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360K	Sell	5,328 -523	-9%	-$31.7K	﹤0.01%	4317
2026 Q1	$324K	Sell	5,851 -246	-4%	-$13.2K	﹤0.01%	4229
2025 Q4	$296K	Buy	+6,097	New	+$238K	﹤0.01%	4048
2018 Q3	–	Sell	-76	Closed	-$5K	–	1300
2018 Q2	$5K	Sell	76 -4	-5%	-$336	﹤0.01%	2634
2018 Q1	$8K	Buy	+80	New	+$9.02K	﹤0.01%	2527

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Envestnet Asset Management's ANAB Position: Q2 2026 in Review

Envestnet Asset Management reduced its AnaptysBio (ANAB) stake by 8.9% in Q2 2026, selling an estimated $31.7K and leaving 5,328 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #4317.

Envestnet Asset Management first reported a position in ANAB in Q1 2018 and has held it in 5 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Envestnet Asset Management held 5,328 shares of AnaptysBio worth $360K as of Q2 2026.
Envestnet Asset Management sold 523 AnaptysBio shares in Q2 2026, an estimated $31.7K.
AnaptysBio made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4317 holding.
Envestnet Asset Management first reported a position in AnaptysBio in Q1 2018 and has held it in 5 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.